SlideShare a Scribd company logo
ACUTE COMPLICATIONS OF
DIABETES MELLITUS
Dr.Sandeep yadav
ACUTE COMPLICATIONS OF
DIABETES MELLITUS
1)Diabetic ketoacidisis
• Precipitating factors
• Signs, symptoms, physical examination, laboratory findings
• Treatment
2)Non ketotic hyperglycemic hyper osmolar coma
• Precipitating factors
• Signs, symptoms, physical examination, laboratory findings
• Treatment
3)Lactoacidosis
• Precipitating factors
• Signs, symptoms, physical examination, laboratory findings
• Treatment
4)Hypoglycemic AND Hypoglycaemic coma
• Precipitating factors
• Signs, symptoms, physical examination, laboratory findings
• Treatment
Hyperglycemia
Ketosis
Acidosis
*
Adapted from Kitabchi AE, Fisher JN. Diabetes Mellitus. In: Glew RA, Peters SP, ed. Clinical
Studies in Medical Biochemistry. New York, NY: Oxford University Press; 1987:105.
Definition of Diabetic Ketoacidosis*
4
Precipitating factors of DKA
• Newly Diagnosed Diabetes
(Presenting Manifestation
• Inadequate Administration Of
Exogenous Insulin;
ABSOLUTE
INSULIN
DEFICIENCY
• Inadequate Administration Of
Exogenous Insulin
• An Intercurrent Infection
(Pneumonia, Cholecyctitis);
• A Vascular Disorder (Myocardial
Infarction, Stroke);
• An Endocrine
Disorder(hyperthyroidism,
Pheochromocytoma);
• Trauma;
• Pregnancy;
• Surgery
RELATIVE
INSULIN
DEFICIENCY
7
Electrolyte
LossesRenal Failure
Shock CV
Collapse
Insulin Deficiency
8
Hyperglycemia
Hyper-
osmolality
Δ MS
Glycosuria
Dehydration
Lipolysis
FFAs
Acidosis
Ketones
CV
Collapse
Insulin Deficiency
9
Electrolyte
LossesRenal Failure
Shock CV
Collapse
Insulin Deficiency
10
Hyperglycemia
Hyper-
osmolality
Δ MS
Lipolysis
FFAs
Acidosis
Ketones
CV
Collapse
Glycosuria
Dehydration
Diabetic Ketoacidosis: Pathophysiology
Unchecked gluconeogenesis  Hyperglycemia
Osmotic diuresis  Dehydration
Unchecked ketogenesis  Ketosis
Dissociation of ketone bodies into
hydrogen ion and anions

Anion-gap metabolic
acidosis
11
• Often a precipitating event is identified (infection, lack of insulin
administration)
12
Clinical Presentation of
Diabetic Ketoacidosis
History Physical Exam
• Thirst
• Polyuria
• Abdominal pain
• Nausea and/or vomiting
• Profound weakness
• Kussmaul respirations
• Fruity breath
• Relative hypothermia
• Tachycardia
• Supine hypotension,
orthostatic drop of blood
pressure
• Dry mucous membranes
• Poor skin turgor
13
Initial Laboratory Evaluation of DKA
• Comprehensive metabolic profile
• Serum osmolality
• Serum and urine ketones
• Arterial blood gases
• CBC
• Urinalysis
• ECG
14
Treatment
REFERENCES:
1) American Diabetic Association
2) British Medical Journal
3) E-medscape
4) Harisson Principle Of Internal Medicine 18th
Edition
5) British Society Of Paediatric Endocrinology
The goals of therapy include:
1.Rehydration
1.Reduction of hyperglycemia
2.Correction of electrolyte imbalance
3. Correction of acid-base imbalance
4.Investigation of precipitating factors,
treatment of complications.
FLUIDS
FLUID RESUSCITATION IS A CRITICAL PART
OF TREATING PATIENTS WITH DKA.
Intravenous solutions replace extravascular and
intravascular fluids and electrolyte losses.
They also dilute both the glucose level and the levels
of circulating counterregulatory hormones.
Fluid it self leads to correction of acidosis to some
extent
Insulin is needed to help switch from a catabolic
state to an anabolic state, with uptake of glucose in
tissues and the reduction of gluconeogenesis as well
as free fatty acid and ketone production
0.9 % NaCl(15-20 ml/kg/hr)
Administer 1-3 L during the first hour.
Administer 1 L during the second hour
Administer 1 L during the following 2
hours
Administer 1 L every 4 hours, depending
on the degree of dehydration and
central venous pressure readings
In general, 0.45% NaCl infused at 4–14 ml · kg−1 ·
h−1 is appropriate if the corrected serum sodium is
normal or elevated
INSULIN RECOMENDATIONS
In adult
patients,
(IfK+ <3.3
mEq/l) , an
IV bolus of
regular
insulin at
0.15 u/kg
body wt
continuous
infusion of
regular
insulin at a
dose of 0.1
unit · kg−1 ·
h−1 (5–7
units/h in
adults),
should be
administered
If plasma
glucose does not
fall by 50 mg/dl
from the initial
value in the 1st
hour, check
hydration
status; if
acceptable, the
insulin infusion
may be doubled
every hour until
a steady glucose
decline between
50 and 75 mg/h
is achieved.
When the
plasma glucose
reaches 250
mg/dl in DKA or
300 mg/dl in
HHS, it may be
possible to
decrease the
insulin infusion
rate to 0.05–0.1
unit · kg−1 ·
h−1 (3–6
units/h), and
dextrose (5–
10%) may be
added to the
intravenous
fluids.
Initiate
subcutaneous
insulin at least 2 h
before
interruption of
insulin infusion
Potassium Repletion in DKA
• K+ >5.2 mEq/L
▫ Do not give K+ initially, but check serum K+ with
basic metabolic profile every 2 h
▫ Establish urine output ~50 mL/hr
• K+ <3.3 mEq/L
▫ Hold insulin and give K+ 20-30 mEq/hr until
K+ >3.3 mEq/L
• K+ = 3.3-5.2 mEq/L
▫ Give 20-30 mEq K+ in each L of IV fluid to
maintain serum K+ 4-5 mEq/L
22
Phosphorus Repletion in DKA
• A sharp drop of serum phosphorus can also
occur during insulin treatment
• Treatment is usually not required
▫ Caregiver can give some K+ as K- phos
23
CORRECTION OF ACID BASE BALANCE
 Its role is controversial
 Sodium bicarbonate only is infused if
decompensated acidosis starts to threaten the
patient's life, especially when associated with either
sepsis or lactic acidosis
 It is recommended for patients in shock and/or if pH
is <6.9

Treatment of Concurrent Infection
• In the presence of infection, the administration
of proper antibiotics is guided by the results of
culture and sensitivity studies. Starting
empirical antibiotics on suspicion of infection
until culture results are available may be
advisable.
Final  acute complications of diabetes mellitus
Criteria for resolution of DKA
 glucose <200 mg/dl,
 serum bicarbonate ≥18 mEq/l, and
 venous pH of >7.3.
Once DKA is resolved, if the patient is NPO,
continue intravenous insulin and fluid
replacement and supplement with subcutaneous
regular insulin as needed every 4 h.
Nonketonic hyperglycemic-hyperosmolar
coma (NKHHC or HNC).
HNC is a syndrome characterized by impaired
consciousness, sometimes accompanied by seizures,
extreme dehydration, , and extreme hyperglycemia
that is not accompanied by ketoacidosis.
HHS
CEREBROV
ASCULAR
ACCIDENTS
,PANCREAT
ITIS,BURN
INFECTIONS
(PNUEMONI
A,UTI)
DRUGS
(STEROIDS
,THIAZIDE
S)
Physical examination
1. Severe dehydration is invariably present.
2. Various neurologic deficits (such as coma, transient
hemiparesis, hyperreflexia, and generalized
areflexia) are commonly present. Altered states of
consciousness from lethargy to coma are observed.
3. Findings associated with coexisting medical
problems (e.g., renal disease, cardiovascular disease)
may be evident.
Laboratory findings
1. Extreme hyperglycemia (blood glucose levels from
30 mmoll/l and over are common.
2. A markedly elevated serum osmolality is present,
usually in excess of 350 mOsm/l. (Normal = 290
mOsm)
3. Serum ketones are usually not detectable, and
patients are not acidic.
4. Serum sodium may be high (if severe degree of
dehydration is present), normal, or high
5. Serum potassium levels may be high (secondary to
the effects of hyperosmolality) Low or normal
DKA and HHS Are Life-Threatening
EmergenciesDiabetic Ketoacidosis (DKA)
Hyperglycemic Hyperosmolar
State (HHS)
Plasma glucose >250 mg/dL Plasma glucose >600 mg/dL
Arterial pH <7.3 Arterial pH >7.3
Bicarbonate <15 mEq/L Bicarbonate >15 mEq/L
Moderate ketonuria or ketonemia Minimal ketonuria and ketonemia
Anion gap >12 mEq/L Serum osmolality >320 mosm/L
32
Treatment
This condition is a medical emergency and the patient
should be placed in an intensive care unit.
Many of the management techniques recommended
for a patient with DKA are applicable here as well.
The goals of therapy include:
• rehydration;
• reduction of hyperglycemia;
• electrolytes replacement;
• investigation of precipitating factors, treatment of
complications.
Lactic acidosis (LA).
DM is one of the major causes of LA, a serious condition
characterized by excessive accumulation of lactic acid
and metabolic acidosis.
The hallmark of LA is the presence of tissue hypoxemia,
which leads to enhanced anaerobic glycolysis and to
increased lactic acid formation.
The normal blood lactic acid concentration is 1 mmol/l,
and the pyruvic to lactic ratio is 10:1. An increase in
lactic acid without concomitant rise in pyruvate leads
to LA of clinical importance.
Predisposing factors
1. Heart and pulmonary failure (which leads to
hypoxia)
2. Alcohol intoxication.
3. Ketoacidosis (it is important to have a very high
index of suspection with respect to presence of LA).
Physical examination
1. Acrocyanosis is common.
2. Tachycardia frequently is present, blood
pressure is decreased.
3. Poor skin tugor and dry skin may be
prominent.
4. Hypothermia is common in LA.
5. Hyperpnea or Kussmaul respiration are
present and related to degree of acidosis.
6. Findings associated with coexisting medical
problems (e.g., renal disease, cardiovascular
disease) may be evident.
Laboratory findings
1. Blood glucose level is not high
2. Glucosurea is absent.
3. Blood lactic acid is high.
Treatment of LA
LA is treated by correcting the underlying cause.
1. Oxygentherapy
2. Metyleneblue (50 – 100 ml of 1 % solution i/v
droply)
3. In severe cases, bicarbonate therapy should be
used (intravenously-infused 2,5 % sodium
bicarbonates 1 to 2 l/day).
4. LA can be treated with low dose insulin
regimens with 5 % glucose solution infusion.
5. Symptomatic therapy:
- Hydrocortisone (250 mg i/v)
- Unitiol (5% solution 10 ml i/v (1- 2 ml/10 kg)
- α-lipoid acid (berlition, espa-lipon)
Comparison of DCA, HNC and LA.
Hypoglycemia
It is a syndrome characterized by symptoms of
sympathetic nervous system stimulation or
central nervous system dysfunction that are
provoked by an abnormally low plasma glucose
level.
Hypoglycemia represents insulin excess and it
can occur at any time.
Precipitating factors
• irregular ingestion of food;
• extreme activity;
• alcohol ingestion;
• drug interaction;
• liver or renal disease;
• hypopituitarism and adrenal insufficiency.
Final  acute complications of diabetes mellitus
Physical examination
1. The skin is cold, moist.
2. Hyperreflexia can be elicited.
3. Hypoglycemic coma is commonly associated
with abnormally low body temperature
4. Patient may be unconsciousness.
Treatment
• The most effective treatment of an insulin reaction is the immediate
ingestion of a concentrated carbohydrate source, such as sugar,
honey, candy, or orange juice.
• Alternative methods for increasing blood glucose may be required
when the person having the reaction is unconscious or unable to
swallow:
▫ Glucagon may be given intramuscularly or subcutaneously.
▫ In situations of severe or life-threatening hypoglycemia, it may be
necessary to administer glucose intravenously.
PREVENTION IS BEST CURE

More Related Content

PPTX
DKA pathophysiology
PPTX
Diabetic Ketoacidosis
PPTX
Management of dm in ckd
PPTX
Diabetic keto acidosis ppt
PPTX
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
PPT
Diabetic dyslipidemia and Saroglitazar
PPTX
Cushing syndrome
PPTX
Acute Complications of Diabetes Mellitus
DKA pathophysiology
Diabetic Ketoacidosis
Management of dm in ckd
Diabetic keto acidosis ppt
Diabetic Ketoacidosis and Hyperglycemic Hyperosmolar State
Diabetic dyslipidemia and Saroglitazar
Cushing syndrome
Acute Complications of Diabetes Mellitus

What's hot (20)

PPTX
Diabetic Ketoacidosis management update
PPTX
Disease of adrenal gland
PPTX
PPTX
Newer anti diabetic drugs
PPTX
9. metabolic syndrome
PPTX
PPTX
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
PPT
DIABETIC KETOACIDOSIS GUIDELINES
PPT
Diabetic emergencies
PPTX
Sick euthyroid syndrome
PPTX
Chronic Kidney Disease, CKD, Nephrology,
PPTX
Diabetic ketoacidosis
PPTX
Diabetic ketoacidosis DKA
PPTX
Addison disease by dr shahjada selim
PPTX
Diabetic Emergencies
PPT
Diabetic Microvascular Complications
PPT
dyslipidemia6.ppt
PPT
Diabetic Ketoacidosis In Children
PPT
Critical care ppt
PPTX
Incretin Therapy
Diabetic Ketoacidosis management update
Disease of adrenal gland
Newer anti diabetic drugs
9. metabolic syndrome
Diabetic ketoacidosis (DKA) MedicalBooksVN.wordpress.com/
DIABETIC KETOACIDOSIS GUIDELINES
Diabetic emergencies
Sick euthyroid syndrome
Chronic Kidney Disease, CKD, Nephrology,
Diabetic ketoacidosis
Diabetic ketoacidosis DKA
Addison disease by dr shahjada selim
Diabetic Emergencies
Diabetic Microvascular Complications
dyslipidemia6.ppt
Diabetic Ketoacidosis In Children
Critical care ppt
Incretin Therapy
Ad

Viewers also liked (20)

PDF
Complications of Diabetes Mellitus
PPT
Brief list diebetes millitis complication
PPTX
Acute complications of Diabetes Mellitus
PPTX
Acute complications of diabetes mellitus
PPT
Acute & chro. complications of d. m.
PPTX
Diabetic Ketoacidosis
PPTX
Lab test and treatment od addison's disease
PPTX
Hyperglycemic Crises
PPT
Cushing's Syndrome and Addison's Disease
PDF
Transient Osteoporosis of Hip
PPTX
Hyperglycaemic emergencies in Diabetes mellitus
PDF
Complications of diabetes melitue
PPTX
Diabetic emergencies
PPT
Complications+of+Diabetes
PPT
Endocrine Emergencies
PPTX
Diabetes mellitus pathophysiol-vnw
PPTX
Diabetes mellitus & Periodontium
PPT
Diabetic keto acidosis in children ... Dr.Padmesh
PPT
Diabetic Microvascular Complications
PPT
Diabetes pathology
Complications of Diabetes Mellitus
Brief list diebetes millitis complication
Acute complications of Diabetes Mellitus
Acute complications of diabetes mellitus
Acute & chro. complications of d. m.
Diabetic Ketoacidosis
Lab test and treatment od addison's disease
Hyperglycemic Crises
Cushing's Syndrome and Addison's Disease
Transient Osteoporosis of Hip
Hyperglycaemic emergencies in Diabetes mellitus
Complications of diabetes melitue
Diabetic emergencies
Complications+of+Diabetes
Endocrine Emergencies
Diabetes mellitus pathophysiol-vnw
Diabetes mellitus & Periodontium
Diabetic keto acidosis in children ... Dr.Padmesh
Diabetic Microvascular Complications
Diabetes pathology
Ad

Similar to Final acute complications of diabetes mellitus (20)

PPTX
PPT
Practical class 04 Acute complications of DM.ppt
PDF
6. Acute DM complications_.pdf Dr Khaled
PPTX
Hyperosmolar hyperglycemic state
PPSX
Interpretation of ketoacidosis (dka) part 2
PDF
Diabetic emergencies.pdf
PPTX
Management of diabetic ketoacidosis
PPTX
Metabolic &amp; endocrine emergencies 2
PPTX
Diabeticketoacidosis presentation 2024- 2
PPT
Honk
PPTX
Lactic Acidosis-An update
PDF
lacticacidosis-150216102857-conversion-gate02.pdf
PPTX
Diabetic emergencies by Riaz........pptx
PPTX
KHA-HHS pp
PPTX
Diabetic ketoacidosis by dr. noman
PPTX
Diabetic ketoacidosis (2)
PPTX
Dka, hhns.pptx1
PPT
JOURNAL diabetic ketoacidosis
PPTX
Diabetic ketoacidosis [DK]
Practical class 04 Acute complications of DM.ppt
6. Acute DM complications_.pdf Dr Khaled
Hyperosmolar hyperglycemic state
Interpretation of ketoacidosis (dka) part 2
Diabetic emergencies.pdf
Management of diabetic ketoacidosis
Metabolic &amp; endocrine emergencies 2
Diabeticketoacidosis presentation 2024- 2
Honk
Lactic Acidosis-An update
lacticacidosis-150216102857-conversion-gate02.pdf
Diabetic emergencies by Riaz........pptx
KHA-HHS pp
Diabetic ketoacidosis by dr. noman
Diabetic ketoacidosis (2)
Dka, hhns.pptx1
JOURNAL diabetic ketoacidosis
Diabetic ketoacidosis [DK]

Recently uploaded (20)

PDF
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
PPTX
Note on Abortion.pptx for the student note
PPTX
Fundamentals of human energy transfer .pptx
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
PDF
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
PDF
july 2025 DERMATOLOGY diseases atlas with hyperlink.pdf
PPTX
post stroke aphasia rehabilitation physician
DOCX
Pathology Paper II – II MBBS Main Exam (July 2025) | New CBME Scheme
PPTX
neonatal infection(7392992y282939y5.pptx
PPTX
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
PDF
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
DOCX
RUHS II MBBS Pathology Paper-II with Answer Key | 1st August 2025 (New Scheme)
PDF
Khadir.pdf Acacia catechu drug Ayurvedic medicine
PDF
coagulation disorders in anaesthesia pdf
PPTX
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPT
Breast Cancer management for medicsl student.ppt
PPTX
SKIN Anatomy and physiology and associated diseases
PPTX
CME 2 Acute Chest Pain preentation for education
Neuro ED Bet Sexologist in Patna Bihar India Dr. Sunil Dubey
Note on Abortion.pptx for the student note
Fundamentals of human energy transfer .pptx
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
POLYCYSTIC OVARIAN SYNDROME.pptx by Dr( med) Charles Amoateng
Writing and Teaching as Personal Documentation of Continuing Professional Dev...
july 2025 DERMATOLOGY diseases atlas with hyperlink.pdf
post stroke aphasia rehabilitation physician
Pathology Paper II – II MBBS Main Exam (July 2025) | New CBME Scheme
neonatal infection(7392992y282939y5.pptx
Patholysiology of MAFLD/MASLD and Role of GLP 1 agonist in obesity and cardio...
Solution of Psycho ED: Best Sexologist in Patna, Bihar India Dr. Sunil Dubey
RUHS II MBBS Pathology Paper-II with Answer Key | 1st August 2025 (New Scheme)
Khadir.pdf Acacia catechu drug Ayurvedic medicine
coagulation disorders in anaesthesia pdf
NEET PG 2025: Memory-Based Recall Questions Compiled by Dr. Shivankan Kakkar, MD
ASRH Presentation for students and teachers 2770633.ppt
Breast Cancer management for medicsl student.ppt
SKIN Anatomy and physiology and associated diseases
CME 2 Acute Chest Pain preentation for education

Final acute complications of diabetes mellitus

  • 1. ACUTE COMPLICATIONS OF DIABETES MELLITUS Dr.Sandeep yadav
  • 3. 1)Diabetic ketoacidisis • Precipitating factors • Signs, symptoms, physical examination, laboratory findings • Treatment 2)Non ketotic hyperglycemic hyper osmolar coma • Precipitating factors • Signs, symptoms, physical examination, laboratory findings • Treatment 3)Lactoacidosis • Precipitating factors • Signs, symptoms, physical examination, laboratory findings • Treatment 4)Hypoglycemic AND Hypoglycaemic coma • Precipitating factors • Signs, symptoms, physical examination, laboratory findings • Treatment
  • 4. Hyperglycemia Ketosis Acidosis * Adapted from Kitabchi AE, Fisher JN. Diabetes Mellitus. In: Glew RA, Peters SP, ed. Clinical Studies in Medical Biochemistry. New York, NY: Oxford University Press; 1987:105. Definition of Diabetic Ketoacidosis* 4
  • 6. • Newly Diagnosed Diabetes (Presenting Manifestation • Inadequate Administration Of Exogenous Insulin; ABSOLUTE INSULIN DEFICIENCY • Inadequate Administration Of Exogenous Insulin • An Intercurrent Infection (Pneumonia, Cholecyctitis); • A Vascular Disorder (Myocardial Infarction, Stroke); • An Endocrine Disorder(hyperthyroidism, Pheochromocytoma); • Trauma; • Pregnancy; • Surgery RELATIVE INSULIN DEFICIENCY
  • 7. 7
  • 8. Electrolyte LossesRenal Failure Shock CV Collapse Insulin Deficiency 8 Hyperglycemia Hyper- osmolality Δ MS Glycosuria Dehydration
  • 10. Electrolyte LossesRenal Failure Shock CV Collapse Insulin Deficiency 10 Hyperglycemia Hyper- osmolality Δ MS Lipolysis FFAs Acidosis Ketones CV Collapse Glycosuria Dehydration
  • 11. Diabetic Ketoacidosis: Pathophysiology Unchecked gluconeogenesis  Hyperglycemia Osmotic diuresis  Dehydration Unchecked ketogenesis  Ketosis Dissociation of ketone bodies into hydrogen ion and anions  Anion-gap metabolic acidosis 11 • Often a precipitating event is identified (infection, lack of insulin administration)
  • 12. 12
  • 13. Clinical Presentation of Diabetic Ketoacidosis History Physical Exam • Thirst • Polyuria • Abdominal pain • Nausea and/or vomiting • Profound weakness • Kussmaul respirations • Fruity breath • Relative hypothermia • Tachycardia • Supine hypotension, orthostatic drop of blood pressure • Dry mucous membranes • Poor skin turgor 13
  • 14. Initial Laboratory Evaluation of DKA • Comprehensive metabolic profile • Serum osmolality • Serum and urine ketones • Arterial blood gases • CBC • Urinalysis • ECG 14
  • 15. Treatment REFERENCES: 1) American Diabetic Association 2) British Medical Journal 3) E-medscape 4) Harisson Principle Of Internal Medicine 18th Edition 5) British Society Of Paediatric Endocrinology
  • 16. The goals of therapy include: 1.Rehydration 1.Reduction of hyperglycemia 2.Correction of electrolyte imbalance 3. Correction of acid-base imbalance 4.Investigation of precipitating factors, treatment of complications.
  • 17. FLUIDS FLUID RESUSCITATION IS A CRITICAL PART OF TREATING PATIENTS WITH DKA. Intravenous solutions replace extravascular and intravascular fluids and electrolyte losses. They also dilute both the glucose level and the levels of circulating counterregulatory hormones. Fluid it self leads to correction of acidosis to some extent Insulin is needed to help switch from a catabolic state to an anabolic state, with uptake of glucose in tissues and the reduction of gluconeogenesis as well as free fatty acid and ketone production
  • 18. 0.9 % NaCl(15-20 ml/kg/hr) Administer 1-3 L during the first hour. Administer 1 L during the second hour Administer 1 L during the following 2 hours Administer 1 L every 4 hours, depending on the degree of dehydration and central venous pressure readings
  • 19. In general, 0.45% NaCl infused at 4–14 ml · kg−1 · h−1 is appropriate if the corrected serum sodium is normal or elevated
  • 21. In adult patients, (IfK+ <3.3 mEq/l) , an IV bolus of regular insulin at 0.15 u/kg body wt continuous infusion of regular insulin at a dose of 0.1 unit · kg−1 · h−1 (5–7 units/h in adults), should be administered If plasma glucose does not fall by 50 mg/dl from the initial value in the 1st hour, check hydration status; if acceptable, the insulin infusion may be doubled every hour until a steady glucose decline between 50 and 75 mg/h is achieved. When the plasma glucose reaches 250 mg/dl in DKA or 300 mg/dl in HHS, it may be possible to decrease the insulin infusion rate to 0.05–0.1 unit · kg−1 · h−1 (3–6 units/h), and dextrose (5– 10%) may be added to the intravenous fluids. Initiate subcutaneous insulin at least 2 h before interruption of insulin infusion
  • 22. Potassium Repletion in DKA • K+ >5.2 mEq/L ▫ Do not give K+ initially, but check serum K+ with basic metabolic profile every 2 h ▫ Establish urine output ~50 mL/hr • K+ <3.3 mEq/L ▫ Hold insulin and give K+ 20-30 mEq/hr until K+ >3.3 mEq/L • K+ = 3.3-5.2 mEq/L ▫ Give 20-30 mEq K+ in each L of IV fluid to maintain serum K+ 4-5 mEq/L 22
  • 23. Phosphorus Repletion in DKA • A sharp drop of serum phosphorus can also occur during insulin treatment • Treatment is usually not required ▫ Caregiver can give some K+ as K- phos 23
  • 24. CORRECTION OF ACID BASE BALANCE  Its role is controversial  Sodium bicarbonate only is infused if decompensated acidosis starts to threaten the patient's life, especially when associated with either sepsis or lactic acidosis  It is recommended for patients in shock and/or if pH is <6.9 
  • 25. Treatment of Concurrent Infection • In the presence of infection, the administration of proper antibiotics is guided by the results of culture and sensitivity studies. Starting empirical antibiotics on suspicion of infection until culture results are available may be advisable.
  • 27. Criteria for resolution of DKA  glucose <200 mg/dl,  serum bicarbonate ≥18 mEq/l, and  venous pH of >7.3. Once DKA is resolved, if the patient is NPO, continue intravenous insulin and fluid replacement and supplement with subcutaneous regular insulin as needed every 4 h.
  • 28. Nonketonic hyperglycemic-hyperosmolar coma (NKHHC or HNC). HNC is a syndrome characterized by impaired consciousness, sometimes accompanied by seizures, extreme dehydration, , and extreme hyperglycemia that is not accompanied by ketoacidosis.
  • 30. Physical examination 1. Severe dehydration is invariably present. 2. Various neurologic deficits (such as coma, transient hemiparesis, hyperreflexia, and generalized areflexia) are commonly present. Altered states of consciousness from lethargy to coma are observed. 3. Findings associated with coexisting medical problems (e.g., renal disease, cardiovascular disease) may be evident.
  • 31. Laboratory findings 1. Extreme hyperglycemia (blood glucose levels from 30 mmoll/l and over are common. 2. A markedly elevated serum osmolality is present, usually in excess of 350 mOsm/l. (Normal = 290 mOsm) 3. Serum ketones are usually not detectable, and patients are not acidic. 4. Serum sodium may be high (if severe degree of dehydration is present), normal, or high 5. Serum potassium levels may be high (secondary to the effects of hyperosmolality) Low or normal
  • 32. DKA and HHS Are Life-Threatening EmergenciesDiabetic Ketoacidosis (DKA) Hyperglycemic Hyperosmolar State (HHS) Plasma glucose >250 mg/dL Plasma glucose >600 mg/dL Arterial pH <7.3 Arterial pH >7.3 Bicarbonate <15 mEq/L Bicarbonate >15 mEq/L Moderate ketonuria or ketonemia Minimal ketonuria and ketonemia Anion gap >12 mEq/L Serum osmolality >320 mosm/L 32
  • 33. Treatment This condition is a medical emergency and the patient should be placed in an intensive care unit. Many of the management techniques recommended for a patient with DKA are applicable here as well. The goals of therapy include: • rehydration; • reduction of hyperglycemia; • electrolytes replacement; • investigation of precipitating factors, treatment of complications.
  • 34. Lactic acidosis (LA). DM is one of the major causes of LA, a serious condition characterized by excessive accumulation of lactic acid and metabolic acidosis. The hallmark of LA is the presence of tissue hypoxemia, which leads to enhanced anaerobic glycolysis and to increased lactic acid formation. The normal blood lactic acid concentration is 1 mmol/l, and the pyruvic to lactic ratio is 10:1. An increase in lactic acid without concomitant rise in pyruvate leads to LA of clinical importance.
  • 35. Predisposing factors 1. Heart and pulmonary failure (which leads to hypoxia) 2. Alcohol intoxication. 3. Ketoacidosis (it is important to have a very high index of suspection with respect to presence of LA).
  • 36. Physical examination 1. Acrocyanosis is common. 2. Tachycardia frequently is present, blood pressure is decreased. 3. Poor skin tugor and dry skin may be prominent. 4. Hypothermia is common in LA. 5. Hyperpnea or Kussmaul respiration are present and related to degree of acidosis. 6. Findings associated with coexisting medical problems (e.g., renal disease, cardiovascular disease) may be evident.
  • 37. Laboratory findings 1. Blood glucose level is not high 2. Glucosurea is absent. 3. Blood lactic acid is high.
  • 38. Treatment of LA LA is treated by correcting the underlying cause. 1. Oxygentherapy 2. Metyleneblue (50 – 100 ml of 1 % solution i/v droply) 3. In severe cases, bicarbonate therapy should be used (intravenously-infused 2,5 % sodium bicarbonates 1 to 2 l/day). 4. LA can be treated with low dose insulin regimens with 5 % glucose solution infusion. 5. Symptomatic therapy: - Hydrocortisone (250 mg i/v) - Unitiol (5% solution 10 ml i/v (1- 2 ml/10 kg) - α-lipoid acid (berlition, espa-lipon)
  • 39. Comparison of DCA, HNC and LA.
  • 40. Hypoglycemia It is a syndrome characterized by symptoms of sympathetic nervous system stimulation or central nervous system dysfunction that are provoked by an abnormally low plasma glucose level. Hypoglycemia represents insulin excess and it can occur at any time.
  • 41. Precipitating factors • irregular ingestion of food; • extreme activity; • alcohol ingestion; • drug interaction; • liver or renal disease; • hypopituitarism and adrenal insufficiency.
  • 43. Physical examination 1. The skin is cold, moist. 2. Hyperreflexia can be elicited. 3. Hypoglycemic coma is commonly associated with abnormally low body temperature 4. Patient may be unconsciousness.
  • 44. Treatment • The most effective treatment of an insulin reaction is the immediate ingestion of a concentrated carbohydrate source, such as sugar, honey, candy, or orange juice. • Alternative methods for increasing blood glucose may be required when the person having the reaction is unconscious or unable to swallow: ▫ Glucagon may be given intramuscularly or subcutaneously. ▫ In situations of severe or life-threatening hypoglycemia, it may be necessary to administer glucose intravenously.